The NWT Medical Association is calling on the territorial government to reinstate universal coverage for HIV and hepatitis B and C treatments.
The GNWT rolled out its income-based Extended Health Benefits program in September 2024, replacing the previous Specific Disease Conditions program for residents not covered by private insurance, Non-Insured Health Benefits or the NWT Métis Health Benefits Program.
Family physician Meaghan McLaren told Cabin Radio while the medical association is “very supportive” of the new public benefits program overall, when it comes to coverage of HIV and hepatitis treatment, “it’s a step back in supporting Canada’s public health goals.”
“It makes sense to have a program that delivers assistance based on means rather than randomly whatever diseases get chosen, regardless of your ability to afford that,” she said. “But specifically for these illnesses that are of concern to the greater public health, they should be covered.”
Canada has committed to meet global targets to eliminate HIV and viral hepatitis as public health threats by 2030.
Since the change in the NWT’s benefits program, McLaren said, 50 percent of residents living with HIV who were previously covered have needed support to be able to stay on their medication. She said she did not have data on the number of people living with hepatitis B and C who have been impacted.
“Can you imagine having a disease that could kill you and you were managing well for many years, and suddenly you can’t afford it?” she said. “Imagine the psychological trauma that causes, as well as physical health.”
McLaren said if a person stops taking HIV medication, it can put them at risk of heart attack and stroke and their sexual partners at risk of infection. She added it can impact the effectiveness of the medication, as it gives the virus a chance to create resistance, potentially requiring different and more expensive medication in future.
Treatment as prevention
The NWT Medical Association asked the territory to reinstate universal coverage for HIV and hepatitis B and C treatments in a July letter to then-health minister Lesa Semmler, arguing the communicable diseases “require a distinct public health approach.”
“Ensuring access to treatment and prevention for communicable diseases regardless of ability to pay is a public health investment that benefits the entire territory,” the letter stated.
The medical association said HIV and hepatitis treatment helps to reduce transmission and is less costly than treating new cases or managing advanced disease.
It pointed out antiretroviral therapy can suppress viral loads to undetectable levels and prevent sexual and mother-to-child transmission of HIV.
Direct-acting antiviral therapy cures more than 98 percent of hepatitis C infections in most patients, the association added, and while chronic hepatitis B is not currently curable, antiviral therapy can reduce transmission risk.
Vaccines for hepatitis B are free for anyone aged six months and older in the NWT. There are currently no approved vaccines for hepatitis C or HIV.
The medical association also reiterated calls for the territory to cover pre-exposure prophylaxis, commonly known as PrEP, for uninsured residents at risk of acquiring HIV. It said the medication reduces the risk of sexually acquired infection by approximately 99 percent when taken as prescribed.
In a territory of approximately 40,000 residents, the association said, the number of people requiring support would be small given existing private insurance and federal coverage.
‘Is the idea just to wait and see?’
Yellowknife North MLA Shauna Morgan raised the issue in the Legislative Assembly earlier this month.
She said universal access to HIV and hepatitis treatments “just makes sense” as it is a best practice used elsewhere in Canada and more cost-effective than treating long-term effects of disease.
While the topic may have “fallen out of the public spotlight,” Morgan said, HIV infection rates have been rising in some Canadian jurisdictions, particularly in rural and isolated communities with limited access to healthcare.
“Front-line doctors are already telling us the need is urgent,” she said.
“Is the idea just to wait and see until we have a major HIV outbreak like Manitoba and Saskatchewan have recently experienced?”
Morgan told the legislature while the health minister had committed to “monitor the situation,” what that would entail was not clear. She called on the GNWT to determine what it would cost to cover the gap for uninsured residents.
According to the latest national surveillance data, 2,288 new cases of HIV were diagnosed across Canada in 2024.
The rate of new diagnoses that year was highest in Manitoba and Saskatchewan, at 19.5 and 18.6 diagnoses per 100,000 people, respectively, compared to a national rate of 5.5. Across the three territories, the rate of new diagnoses was 4.6 cases per 100,000 residents.
In 2024, 70,900 Canadians were living with HIV. That year, 128 deaths were attributed to HIV in Canada, a figure the federal government said was likely underreported.
Data indicates 3,524 cases of hepatitis B and 7,535 cases of hepatitis C were reported across Canada in 2021.
GNWT focused on screening
Responding to Morgan in the legislature, new NWT health minister Denny Rodgers said the chief public health officer’s office has committed to an independent review of coverage models for treatment and prevention to “help inform future decisions on how we can cover these medications.”
Rodgers said that review will look at what other jurisdictions are doing as well as available data on coverage gaps, and will include costing. He said a broad public survey and extensive engagement with front-line staff will not be part of the review, given timelines and capacity.
“Any change to the drug coverage must be weighted carefully to consider population health needs, how well programs work, affordability and the sustainability of the overall health system,” he said.
Rodgers said NWT public health supports routine screening to stop transmission before outbreaks happen.
“Our biggest challenge is reaching people who don’t come in for regular screening,” he said. “That’s where we must keep focusing our efforts.”
McLaren said while the NWT Medical Association is currently asking the territory to adjust its public coverage policy for HIV and hepatitis treatments, they would likely be covered if Canada had an expanded national pharmacare program.
“If we had universal coverage it would be less expensive and it would be available to everybody, so I think ultimately that’s what’s needed in Canada,” she said.
The federal government passed legislation for the first phase of a national universal pharmacare program, focused on birth control and diabetes medication, in late 2024. Canada signed bilateral pharmacare agreements with BC, Manitoba, PEI and Yukon in early 2025.
Expansion of the program has since stalled.
The federal government’s latest budget does not include funding for additional pharmacare deals.










